Laddar...

Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species

CD101 is a novel echinocandin with a long half-life undergoing clinical development for treatment of candidemia/invasive candidiasis and vulvovaginal candidiasis. The potential for and mechanisms underlying the development of resistance to CD101 in Candida species were investigated by using spontane...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Antimicrob Agents Chemother
Huvudupphovsmän: Locke, Jeffrey B., Almaguer, Amanda L., Zuill, Douglas E., Bartizal, Ken
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2016
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5038289/
https://ncbi.nlm.nih.gov/pubmed/27480852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00620-16
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!